PROTAC, a highly promising drug development technology, facilitates rapid degradation of target proteins by connecting them to E3 recruiting enzymes. Shanghai VKEY Biotechnologies Co.,Ltd. provides a comprehensive PROTAC drug screening solution, including services for screening properties like transmembrane capability and trimer complex formation of PROTAC molecules.